111 Inc
YI3.160USD
-0.533-14.44%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
160.13MMarket Cap
LossP/E TTM
More Details of 111 Inc Company
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
111 Inc Info
Ticker SymbolYI
Company name111 Inc
IPO dateSep 12, 2018
CEOLiu (Junling)
Number of employees1238
Security typeDepository Receipt
Fiscal year-endSep 12
Address3-4/F, No.295 Zuchongzhi Road
CitySHANGHAI
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code201203
Phone862120536666
Websitehttp://corporate.111.com.cn/
Ticker SymbolYI
IPO dateSep 12, 2018
CEOLiu (Junling)
Company Executives of 111 Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product Revenues
3.51B
99.44%
Service Revenues
19.70M
0.56%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product Revenues
3.51B
99.44%
Service Revenues
19.70M
0.56%
Shareholding Stats
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Geode Capital Management, L.L.C.
0.05%
Other
90.43%
Shareholders
Shareholders
Proportion
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Geode Capital Management, L.L.C.
0.05%
Other
90.43%
Shareholder Types
Shareholders
Proportion
Private Equity
15.64%
Corporation
8.57%
Venture Capital
7.15%
Investment Advisor
0.62%
Hedge Fund
0.26%
Research Firm
0.11%
Investment Advisor/Hedge Fund
0.05%
Other
67.61%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
42
1.21M
23.79%
-403.88K
2025Q2
48
1.99M
39.33%
-416.92K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
2023Q3
57
2.15M
44.81%
-47.43K
2023Q2
64
2.05M
43.37%
+895.26K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
14.77K
0.29%
+14.77K
--
Jun 30, 2025
Renaissance Technologies LLC
13.01K
0.26%
+200.00
+1.56%
Jun 30, 2025
Morgan Stanley & Co. LLC
5.14K
0.1%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
6.12K
0.12%
+4.66K
+320.77%
Jun 30, 2025
SBI Securities Co., Ltd.
224.00
0%
-38.00
-14.50%
Jun 30, 2025
J.P. Morgan Securities LLC
8.00
0%
-62.00
-88.57%
Jun 30, 2025
Parametric Portfolio Associates LLC
27.00
0%
--
--
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
22.00
0%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
Proportion0%
SPDR Portfolio Emerging Markets ETF
Proportion0%
SPDR S&P Emerging Asia Pacific ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Date
Type
Ratio
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
FAQs
Who are the top five shareholders of 111 Inc?
The top five shareholders of 111 Inc are:
First Pharmacia International holds 434.53K shares, accounting for 8.57% of the total shares.
Susquehanna International Group, LLP holds 14.77K shares, accounting for 0.29% of the total shares.
Renaissance Technologies LLC holds 13.01K shares, accounting for 0.26% of the total shares.
Morgan Stanley & Co. LLC holds 5.14K shares, accounting for 0.10% of the total shares.
UBS Financial Services, Inc. holds 6.12K shares, accounting for 0.12% of the total shares.
First Pharmacia International holds 434.53K shares, accounting for 8.57% of the total shares.
Susquehanna International Group, LLP holds 14.77K shares, accounting for 0.29% of the total shares.
Renaissance Technologies LLC holds 13.01K shares, accounting for 0.26% of the total shares.
Morgan Stanley & Co. LLC holds 5.14K shares, accounting for 0.10% of the total shares.
UBS Financial Services, Inc. holds 6.12K shares, accounting for 0.12% of the total shares.
What are the top three shareholder types of 111 Inc?
The top three shareholder types of 111 Inc are:
First Pharmacia International
Susquehanna International Group, LLP
Renaissance Technologies LLC
First Pharmacia International
Susquehanna International Group, LLP
Renaissance Technologies LLC
How many institutions hold shares of 111 Inc (YI)?
As of 2025Q3, 42 institutions hold shares of 111 Inc, with a combined market value of approximately 1.21M, accounting for 23.79% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -15.54%.
What is the biggest source of revenue for 111 Inc?
In FY2025Q1, the Product Revenues business generated the highest revenue for 111 Inc, amounting to 3.51B and accounting for 99.44% of total revenue.
